ACAD
#1341
ACADIA Pharmaceuticals Inc. - Common Stock
29.7 3 USD
+0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.51%
Monthly Change
+13.82%
6 month change
+22.80%
Year Change
+13.52%
Previous Close
29.5 8
Open
29.7 3
Low
29.7 3
High
29.7 3
Volume
98
Financials
- Market Capitalization 5.12 B
- Employee 798
- Founded 1993
- CEO Catherine Owen Adams
- Website www.acadia.com
- Headquarter Delaware, United States
- FIGI BBG000BHG9K0
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
11.61
Price to sales ratio
4.24
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1261 |  CRSP CRISPR Therapeutics AG - Common Shares | 59.37 USD | +0.24% | -0.59% | +25.20% | +12.08% | 5.74 B USD | ||
| 1272 |  LGND Ligand Pharmaceuticals Incorporated - Common Stock | 284.52 USD | -1.16% | -1.24% | -3.43% | +52.05% | 5.67 B USD | ||
| 1374 |  DYN Dyne Therapeutics, Inc. - Common Stock | 26.09 USD | -1.02% | -0.50% | +0.50% | +11.45% | 4.87 B USD | ||
| 1386 |  EWTX Edgewise Therapeutics, Inc. - Common Stock | 44.19 USD | -0.43% | +1.49% | +9.54% | +190.15% | 4.80 B USD |
Frequently asked questions about Acadia Pharmaceuticals Inc.
What is the Acadia Pharmaceuticals Inc. stock price today?
The current price of Acadia Pharmaceuticals Inc. (ACAD) is 29.73. Over the past 24 hours, the stock has changed by +0.51%. Follow the ACAD chart for real-time price dynamics.
What is the stock ticker of Acadia Pharmaceuticals Inc.?
Acadia Pharmaceuticals Inc. trades under the ticker ACAD. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Acadia Pharmaceuticals Inc. stock going up?
ACAD has changed by +2.24% over the last week, +13.82% over the last month, and +13.52% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Acadia Pharmaceuticals Inc.?
Acadia Pharmaceuticals Inc. currently has a market capitalization of 5.12 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Acadia Pharmaceuticals Inc. earnings last quarter?
Last quarter, Acadia Pharmaceuticals Inc. reported earnings of 0.18 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Acadia Pharmaceuticals Inc. revenue for the last quarter?
Acadia Pharmaceuticals Inc. reported quarterly revenue of 307.96 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Acadia Pharmaceuticals Inc. net income for the last quarter?
Acadia Pharmaceuticals Inc. reported net income of 31.5 M for the last quarter. The previous quarter showed 3.64 M, which means net income changed by +766.10%.
How many employees does Acadia Pharmaceuticals Inc. have?
As of the latest available data, Acadia Pharmaceuticals Inc. has 798 employees. Workforce size can provide additional context about the company's scale and operations.
What is Acadia Pharmaceuticals Inc. EBITDA?
Acadia Pharmaceuticals Inc. EBITDA is 43.66 M, and its EBITDA margin is 14.18%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Acadia Pharmaceuticals Inc. stock?
You can buy Acadia Pharmaceuticals Inc. (ACAD) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Acadia Pharmaceuticals Inc. stock?
Investing in Acadia Pharmaceuticals Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ACAD chart and related analysis on metatrader.com as part of your research.